THE INSTITUTE'S TECHNOLOGICAL PRODUCTS

At the Institute we are looking for partners to develop or commercialise our knowledge and technology.

pdf-icon New Gramine Derivatives
pdf-icon pdf-icon Brain Dynamics
pdf-icon pdf-icon e-PIC: NON-INVASIVE TECHNOLOGY TO MEASURE INTRACRANIAL PRESSURE
pdf-icon pdf-icon NEW MANDIBULAR DISTRACTOR
pdf-icon NEW ORAL TREATMENT FOR MULTIPLE SCLEROSIS
pdf-icon pdf-icon BRAINGUARD: NEW METHOD TO PREDICT MIGRAINE ATTACKS
pdf-icon PROGNOSTIC METHOD FOR AUTOIMMUNE DISEASE BY GENOTYPING GENETIC VARIANTS OF VASOACTIVE INTESTINAL PEPTIDE
pdf-icon USE OF DUAL INHIBITING COMPOUNDS OF GSK3B – ACHE AND NRF2 INDUCERS IN THE TREATMENT OF NEURODEGENERATIVE DISEASE
pdf-icon COMPOUNDS DERIVED FROM 3-ALKYLAMINE-1H-INDOLYL ACRYLATE AND THEIR USE IN TREATING DISEASES
pdf-icon NEW DERIVATIVES OF DIMETHYLAMINE WITH Ca2+ BLOCKING ACTIVITY DEPENDENT ON VOLTAGE, AND THEIR APPLICATION IN THE TREATMENT OF NERVOUS SYSTEM DISEASES
pdf-icon NEW COMPOUNDS WITH MITOCHONDRIAL SODIUM/CALCIUM EXCHANGER BLOCKING ACTIVITY
pdf-icon LYMPHOCYTES CROSS-INFECTED FOR TUMOUR TREATMENT